Merck KGaA

Merck KGaA sees immunotherapy drug holding its own in cancer race
Yahoo/Reuters
Tue, 06/2/15 - 09:06 am
Merck KGaA
avelumab
Pfizer
ASCO
cancer immunotherapy
Merck KGaA poaches Sanofi oncology exec Zhen Su
Fierce Biotech
Fri, 05/29/15 - 12:18 pm
Merck KGaA
Sanofi
oncology
Merck KGaA Earnings Miss Estimates on Cancer Drug Research
Bloomberg
Tue, 05/19/15 - 10:45 am
Merck KGaA
earnings
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Yahoo/Reuters
Tue, 05/12/15 - 10:19 am
Merck KGaA
Threshold Pharmaceuticals
pancreatic cancer
FDA
fast track
evofosfamide
Merck KGaA to tap Oschmann as new CEO, sources report
Fierce Pharma
Fri, 03/20/15 - 11:03 am
Merck KGaA
Pharma CEOs
Stefan Oschmann
Merck KGaA pitches in an extra $3M to support Opexa's PhIIb for MS
Fierce Biotech
Mon, 03/9/15 - 12:01 pm
Merck KGaA
Opexa
Serono
MS
multiple sclerosis
Merck's Rebif held its own in last year's MS market shakeup. What about 2015?
Fierce Pharma
Tue, 03/3/15 - 01:27 pm
Rebif
MS
multiple sclerosis
Merck KGaA
Germany's Merck sees slight core profit rise in 2015
Yahoo/Reuters
Tue, 03/3/15 - 08:16 am
Merck KGaA
earnings
Merck KGaA carves into MS R&D after a string of setbacks
Fierce Biotech
Mon, 02/23/15 - 10:16 am
Merck KGaA
MS
multiple sclerosis
R&D
Merck KGaA abandons Symphogen's cancer drug ahead of Phase III
Fierce Biotech
Thu, 01/29/15 - 09:39 am
Merck KGaA
Symphogen
Sym004
Pfizer's hunting for safe M&A bets, not high-risk pipeline deals
Fierce Biotech
Wed, 01/28/15 - 07:50 am
Pfizer
M&A
Actavis
Teva Pharmaceutical
AstraZeneca
Merck KGaA
Pfizer to Skip Melanoma in Bid to Join Cancer Race
Bloomberg
Thu, 01/15/15 - 08:48 am
Pfizer
melanoma
Merck KGaA
R&D
Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen
Seeking Alpha
Fri, 11/21/14 - 03:13 pm
Pfizer
Merck KGaA
CompuGen
[video]Merck KGaA Won't Play Part in Consolidation, Kley Says
Bloomberg
Mon, 11/17/14 - 08:33 am
Merck KGaA
Pfizer
cancer immunotherapy
MSB0010718C
Pfizer to Buys Merck KGaA Cancer Drug Rights
Bloomberg
Mon, 11/17/14 - 07:06 am
Pfizer
Merck KGaA
cancer immunotherapy
MSB0010718C
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
[video]Merck KGaA to acquire Sigma-Aldrich for $17 billion
CNBC
Mon, 09/22/14 - 08:01 am
Merck KGaA
M&A
Sigma-Aldrich
Is Merck KGaA on Track with its "Fit for 2018" Program?
Yahoo/Zacks
Sat, 09/20/14 - 08:50 am
Merck KGaA
Merck KGaA seeks partner for immuno-oncology drug by year-end
Yahoo/Reuters
Thu, 09/18/14 - 08:55 am
Merck KGaA
immuno-oncology
anti-PD-L1
Merck KGaA agrees to market Lupin drugs in emerging countries
Yahoo/Reuters
Tue, 09/16/14 - 11:58 am
Merck KGaA
Lupin
emerging markets

Pages